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Abstract
During human embryonic development, odontogenic tissues, 
deriving from the neural crest, remain undifferentiated until 
the adult age. This study was aimed at characterising the 
cells of the follicle enveloping the dental germ, due to its 
direct origin from neural crests. Sixty dental follicles were 
collected from patients aged 18 to 45 years. This research 
has clarified that dental follicles, if extracted in a very early 
stage, when dental roots did not start to be formed, contain a 
lineage of cells, characterised by a high degree of plasticity 
in comparison with other adult stem cell populations. In 
particular, we found that these cells share the following 
features with ES: (i) high levels of embryonic stem cell 
markers (CD90, TRA1-60, TRA1-81, OCT-4, CD133, and 
SSEA-4); (ii) mRNA transcripts for Nanog and Rex-1; (iii) 
broader potency, being able to differentiate in cell types of 
all three germ layer, including smooth and skeletal muscle, 
osteoblasts, neurons, glial cells, and adipocytes; (iv) high 
levels of telomerase activity; (v) ability to form embryoid 
bodies; (vi) ability, after injection in murine blastocysts, to 
be localised within the inner cell mass; (vii) no teratoma 
formation after injection; (viii) in vivo tissue formation after 
transplantation. Our results demonstrate that these cells 
represent a very easy accessible and extraordinary source 
of pluripotent cells and point out the fact that they own the 
cardinal feature of embryonic stem cells.
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Introduction
During human embryonic development, neural crest 
cells migrate from the most dorsal region of the neural 
tube by day 30 to the head, neck, and other regions of 
the body. In the craniofacial region, these cells penetrate 
the mesenchyme, reinforcing it, and then differentiate 
into cartilage, bone, neurons, glial cells, and connective 
tissues of the cranium and face. In the trunk region, 
these cells differentiate into peripheral neurons and 
muscular-connective tissue of large arteries. In addition, 
the extracellular matrix exerts an important signalling 
cue, acting as an epigenetic guide of gene expression. 
Therefore, neural crest cells are strictu sensu pluripotent 
cells (Betters et al., 2010; O’Rahilly and Muller, 2007). 
However, to date they have been isolated only from 
embryonic tissues at an early stage of development (Zhou 
and Snead, 2008).
 Embryologically, teeth are ectodermal organs 
originating from sequential reciprocal interactions 
between oral epithelial cells (ectoderm) and cranial neural 
crest-derived mesenchymal cells (Chai et al., 2000; Imai et 
al., 1996). The epithelial cells give rise to enamel forming 
ameloblasts, and the mesenchymal cells form all other 
differentiated cells (e.g., dentine forming odontoblasts, 
pulp, periodontal ligament) (Volponi et al., 2010). Among 
the transient structures of teeth, the dental follicle that is 
a loose ectomesenchyme-derived connective tissue sac 
surrounding the enamel organ and the dental papilla of the 
developing tooth germ before eruption, it is known, up to 
now, that it contains progenitor cells for cementoblasts, 
periodontal ligament (PDL) and osteoblasts (Volponi et 
al., 2010).
 This led us to search for an adult source of neural 
crest cells. On the assumption that the craniofacial region 
of the adult body largely originates from these cells, we 
focused on this area. We decided to study the dental sac 
as a potential source of these cells because of the clinical 
observation of the persistence during adult life of the 
dental follicle, which envelops the crown of impacted 
teeth.
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 In this study, we provide evidence that the dental follicle 
comprises cells having all the characteristics of neural 
crest cells. The follicle of impacted teeth sealed within 
maxillary and mandible bones can be collected in humans 
with a simple surgical procedure, and their cells quickly 
selected and cultured in vitro.
 We show that Dental Follicle neural crest-derived cells 
(DFCs) constitute an embryonic-like stem cell population 
found within the adult, which co-express early neural 
progenitor markers and vascular endothelial growth factor 
receptors, including Brn3a and flk-1, and retain embryonic 
markers and transcription factors, such as Oct-4, Nanog, 
TRA1-60, and TRA-1-80-1.
 All these markers, according to National Institute of 
Health (NIH) guidelines, are specific for human embryonic 
stem cells. After challenging them with differentiation 
cues, DFCs easily and efficiently gave rise to neurons, 
osteoblasts, adipocytes, and other cytotypes; thus, they 
have the same pluripotency as neural crest cells (Lin et al., 
2006). Due to their embryonic features, which are assessed 
in this study and include, among others, (i) the ability to 
form embryonic bodies; (ii) integration into the inner cell 
mass of blastocysts; (iii) pluripotency both in vitro and 
in vivo, and (iv) a very high level of telomerase activity, 
the clinical use of these cells may advance reconstruction 
therapy.
Materials and Methods
Subjects, dental follicle extraction, digestion, and culture
Sixty early stage dental follicles, extracted from dental 
germs in which the roots were completely absent, were 
collected during wisdom tooth extraction from patients 
aged 18 to 45. Each patient was checked for systemic 
and oral infection and diseases before extraction. Only 
disease-free patients were selected for follicle collection. 
Each follicle was gently removed and dipped in a digestive 
solution (penicillin 100 U/mL/streptomycin 100 μg/mL, 
claritromycin 500 μg/mL, 3 mg/mL type I collagenase, 
4 mg/mL dispase in PBS (phosphate buffered saline) 
for 1 h at 37 ºC. Once digested, the solution was filtered 
with 70 μm Falcon strainers (Becton & Dickinson (BD), 
Franklin Lakes, NJ, USA) and the cells immersed in 
MEGACELL culture medium, supplemented with 10 % 
foetal calf serum (FCS), bFGF 2 μM, 100 μM 2P-ascorbic 
acid, 2 mM L-glutamine, 100 U/mL penicillin, and 
100 μg/mL streptomycin (pen-strep) (all purchased from 
Invitrogen, San Giuliano Milanese, Milan, Italy) and 
placed in 75 mL flasks with filtered valves. Flasks were 
incubated at 37 ºC in a 5 % CO2 and the medium changed 
twice a week. As soon as cells became confluent, they were 
subdivided into new flasks. 
 Stem cells were sorted for SSEA-4 antigen at passage 
5, using a FACS Aria II BD (BD Biosciences) when their 
number was at least 1,000,000 per flask. Human gingival 
fibroblasts were used as controls.
Colony efficiency assays and proliferation potential
To evaluate colony efficiency and proliferation potential, 
single cells obtained by limiting dilutions were plated. 
Clone and cell numbers were evaluated. After three weeks 
of culture, cells were stained with 0.1 % (w/v) toluidine 
blue in 1 % paraformaldehyde. The number of clones (>50 
cells) was counted.
Fluorescence-activated cell sorting
At least 1,000,000 cells per sample were detached using 
0.02 % EDTA solution in PBS and pelleted (10 min 
at 1,000rpm), washed in 0.1 % bovine serum albumin 
(BSA) in PBS at 4 ºC, then incubated in a solution of 
1 μL antibody/9 μL 0.1 % BSA in PBS. Cells were then 
washed in the same solution (see above) and were ready 
for observation. Antibodies were the following: SSEA-
4, TRA1-60, TRA1-81, CD90, CD133, OCT-4, flk-1 
(all Santa Cruz, Santa Cruz, CA, USA), Tuj1, Brn3A, 
SMA (BD Biosciences), all mouse anti-human. For Tuj1, 
Brn3A, SMA and OCT-4 analyses, cells were fixed in 4 % 
paraformaldehyde in PBS, with 0.2 % Triton X100 for 
30 min at 4 ºC, washed twice in 0.1 % BSA in PBS and 
then incubated with antibody.
Reverse transcriptase polymerase chain reaction 
(PCR) analysis
Total RNA was extracted from 1,000,000 non-sorted 
cells for each analysis by homogenisation in TRI 
Reagent (Sigma-Aldrich, Milan, Italy), following the 
manufacturer’s instructions, incubated with DNase (Takara 
Bio Ink, Shiga, Japan) for 1 h at 37 ºC and stored at -80 ºC. 
cDNA synthesis was carried out from total RNA using 
Superscript II reverse transcriptase (Invitrogen Celbio Italy, 
San Giuliano Milanese, Milan, Italy) and oligo (dT)12-18, 
following the manufacturer’s instructions.
 PCR analyses were performed using a TC-312 thermal 
cycler (Techne, Burlington, NJ, USA), under the following 
conditions: 2 min denaturing step to 94 ºC, 35 cycles 
of 94 ºC for 30 s, 54 ºC for 45 s, 72 ºC for 1 min and a 
final extension step at 72 ºC for 4 min. The PCR mixture 
contained 0.2 mM of each dNTP, 1.5 mM MgCl2, 0.2 μM 
of each primer. The primer sequences were: forward Rex-
1 5’-GGCAAAGACAAGACACCAG-32; and reverse 
52-TTTCCCACATTCCGCA CAG-32; Nanog primers 
5’-GCTGAGATGCCTCACACGGAG-3’ (forward) and 
5’-TCTGTT TCTTGACTGGGACCTTGTC-3’ (reverse); 
β-actin 5’-TGT GAT GGT GGG AAT GGG TCA G-3’; 
reverse β-actin 5’-TTT GAT GTC ACG CAC GAT TTC 
C-3’. The PCR annealing was performed at 54 ºC as 
the β-actin primers are from mouse and contain some 
mismatch to human. This can be overcome for qualitative 
analysis of human samples by using a reduced annealing 
temperature. The amplification products were separated on 
2 % agarose gel in Tris acetate EDTA (TAE) buffer. PCRs 
were performed on RT-negative samples to exclude DNA 
contamination.
Histochemistry
Fifteen days after isolation, cells were challenged for 
alkaline phosphatase production (ALP). Cells were 
washed in PBS 1M and fixed in 4 % paraformaldehyde 
in PBS, with 0.2 % Triton X100 for 30 min at 4 ºC, then 
washed twice in 0.1 % BSA in PBS at room temperature 
for 10 min each. Cells were covered using ALP standard 
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solution, incubated in the dark for 8 h. ALP activity was 
measured using 100,000 cells/sample, detached by PBS/
EDTA 0.02 %, and centrifuged for 10 min at 140 g. The 
pellet was incubated with 1 mL of BMPurple solution 
(Roche, Segrate, Milan, Italy) for 8 h in dark. Supernatant 
was read in a spectrophotometer at 615 nm. As control, 
gingival fibroblasts were used. The values were expressed 
as a ratio between sample and BMPurple stock solution. 
BMPurple solvent was used as blank.
Sphere cluster formation (embryoid bodies)
In order to observe if dental follicle cells were able to 
form embryoid bodies, cells were plated at a density of 
60,000 cells/well in 6-well ultra low attachment plates 
(Corning Inc., Corning, NY, USA) in Mega cell medium 
supplemented with 1 % methylcellulose, progesterone 
(10 nM), putrescine (50  μM), sodium selenite (15 nM), 
transferrin (13 μg/mL), insulin (10 μg/mL; Sigma-Aldrich), 
human EGF (10 ng/mL), and human bFGF (10 ng/mL; 
Sigma). Fresh aliquots of bFGF were added every other 
day. After culture for 48-72 h, spheres were visible under 
inverted phase-contrast microscopy (Nikon TS 100, Nikon, 
Tokyo, Japan).
Telomeric repeat amplification and quantification 
protocol (TRAPeze ELISA)
Assays were performed using the TRAPeze ELISA 
Telomerase detection Kit (MP QBiogen, Irvine, CA, USA), 
according to the manufacturer’s instructions. In brief, 
cell extracts were incubated with biotinylated telomerase 
substrate oligonucleotide at 30 ºC for 30 min. The extended 
products were amplified by PCR using Taq polymerase 
(Amersham Biosciences, Orsay, France), biotinylated 
telomerase substrate oligonucleotide, reverse primers, 
and a deoxynucleotide mix containing dCTP labelled 
with dinitrophenyl. The PCR conditions were: 33 cycles 
of 94 ºC for 30 s and 55 ºC for 30 s on a GeneAmpPCR 
System 9700 thermocycler (Applera/Applied Biosystems, 
Courtaboeuf, France). The amplification products were 
immobilised on streptavidin-coated microtiter plates and 
then detected by antidinitrophenyl antibody conjugated 
to horseradish peroxidase. After addition of peroxidase 
substrate (3,3_,5,5_-tetramethylbenzidine), the amount 
of TRAP products was determined by measuring the 
absorbance at 450 and 690 nm. To confirm the results of 
the ELISA, amplified products were resolved by 12.5 % 
nondenaturing. Gels were stained with SYBRgreen 
(Invitrogen) (dilution 1/10,000), and PCR amplification 
products were visualised under UV light. Furthermore, 
because telomerase has an essential RNA component, 
aliquots of samples were treated with RNAase to assess 
the specificity of the reaction. Telomerase activity was 
measured twice on protein samples obtained from each cell 
fraction from two independent preparations. To compare 
the different stem cell populations in the same experiment, 
assays were performed on 1,800 sorted cells to be in the 
semiquantitative conditions (OD values between 0.2 
and 1.5). Data are means of four different experiments. 
Data were statistically compared by t tests. The protein 
concentration was determined using the QuantiPro BCA 
assay kit (Sigma-Aldrich) and BSA as a standard. The 
tested samples were the following: i. HeLa, cancer cell 
line used as positive control; ii. cells positive and negative 
for SSEA-4 after sorting (day 0); and ii. cells positive 
and negative for SSEA-4 after 18 and 46 d of adipogenic 
differentiation.
Injection of DFCs in murine blastocysts
SSEA-4+ cells were selected from dental follicles of 
healthy subjects. The use of human DFC cells for injection 
into murine blastocysts was approved by the Internal Ethic 
Committee. Green fluorescent protein (GFP) cells were 
obtained after infection of SSEA-4+ cells with lentivirus. 
The presence of human-specic DNA within the blood 
and organs of mouse embryos was evaluated by PCR 
amplifying an 850-bp fragment of the a-satellite region of 
the human chromosome 17, using primers corresponding 
to the primer pair 17a1/17a2 as described by Warburton 
et al. (1991).
 Ten murine blastocysts were isolated from donor 
C57BL/6 on day 3.5 of gestation, and 40 SSEA-4+/GFP+ 
cells were injected into each blastocyst. After 24 h, 48 h 
and 72 h, blastocysts were observed at phase contrast using 
fluorescent light microscopy.
In vivo teratoma formation
NOD/SCID mice (genotype NOD/NCrCrl-Prkdcscid) 
were obtained from Charles River Italia (Calco, Lecco, 
Italy) and housed in the single-barrier animal facility of 
the Faculty of Medicine, University of Pavia. Mice were 
fed ad libitum with a standard diet and water. In order to 
assess the capability of DFC to form teratomas in vitro, 
5,000,000 cells were injected in each of 12 NOD-SCID 
mice into the skin fold of the inner thigh, using a 27 gauge 
syringe, of four mice per group. After 2-3 weeks, animals 
were sacrificed and emerging tissue material was dissected. 
Tissue was fixed in formalin and embedded in paraffin. 
Sections were stained in haematoxylin-eosin according 
to standard procedures. This examination was performed 
according to our internal ethic committee.
In vitro differentiation
Osteoblasts and bone
To differentiate cells into osteoblasts and then in a bone 
tissue, we used α-MEM culture medium supplemented 
of a 20 % foetal bovine serum (FBS), 1 % pen-strep, 
dexamethasone (0.1 μM, Sigma-Aldrich), ascorbate-2-
phoshate (50 μM, Sigma-Aldrich), and β-glycerophosphate 
(100 μM, Sigma-Aldrich). Flasks were incubated at 37 ºC 
under 5 % CO2, the medium changed twice a week, and 
cells were not split for 5 weeks.
 As we have previously shown (Laino et al., 2005, 
2006), extended culture in high percentage FBS stimulates 
differentiation. This, together with the long period during 
which cells were not split, to favour mechanical stability 
and extracellular matrix deposition, helps osteoblastic 
differentiation and bone formation. After differentiation, 
cells were challenged for bone markers including RUNX-
2 and OC at FACScanning; and OC, BAP, BSP, collagen 
type 1, and RUNX-2 at the immunofluorescence.
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Skeletal muscle
To stimulate myogenic differentiation, sorted cells were 
co-cultured with C2C12, a mouse myogenic cell line, and 
tested for their capacity to fuse with C2C12 and participate 
in new myofibre formation. Human stem cells were 
cocultured with C2C12 (1:5) in ATCC medium: Dulbecco’s 
modified Eagle’s medium (DMEM, Invitrogen), with 
4 mM L-glutamine adjusted to contain 1.5 g/L sodium 
bicarbonate, 4.5 g/L glucose, and 1.0 mM sodium 
pyruvate, 90 %, permissive for myogenic differentiation, 
added of 10 % FCS, for one week and fixed with 4 % 
paraformaldehyde. Double immunofluorescence was 
performed with anti-myosin antibody (rabbit anti-mouse, 
Santa Cruz) and an anti-human nuclear lamins A and C 
monoclonal antibody (Novocastra, Newcastle, U.K.).
Smooth muscle
To obtain smooth muscle differentiation, cells were 
placed in MEGACELL medium (see above) with 2 % 
FBS and 10 ng/mL transforming growth factor (TGF)β. 
Smooth muscle differentiation was obtained in 4-5 d either 
spontaneously or with this technique. After differentiation, 
cells were challenged for SMA antigen.
Adipocytes
To obtain adipocytes, the culture medium was supplemented 
with 10 % FBS, dexamethasone (1 μM, Sigma-Aldrich), 
recombinant human insulin (10 μM, Sigma-Aldrich), 
indomethacin (200 μM, Sigma-Aldrich), and 3-isobutil-
1-methyl-xanthine (IBMX, 0.5 mM, Sigma) twice a 
week for six weeks. In order to identify lipid-laden fat 
cells, immunohistochemical analyses were performed 
with a DAKO CYTOMATION kit (En Vision + System-
HRP-AEC, Dako Italia, Milan, Italy) according to the 
manufacturer’s protocol. Antibodies used were anti-
adiponectin and anti-PPAR-γ (Peroxisome proliferator-
activated receptor-γ) (purchased from AbCam, Cambridge, 
UK).
Astrocytes, olygodendrocytes and neurons
1,000 DFCs (third passage) were plated onto Lab-Tek 
Chamber-Slides (Nalge Nunc International, Rochester, 
NY, USA) and incubated in normal growth medium: 
MEGACELL (Sigma-Aldrich) with 2 % foetal bovine 
serum (Euro Clone, Siziano, PV, Italy), 10 ng/mL bFGF, 
Ascorbic acid 0.005 g/250 mL (Sigma-Aldrich), 1 % 
L-Glutamine and 1 % Penicillin-Streptomycin (Euro 
Clone). Cells were maintained at 37 ºC in humidified 95 % 
air/5 % CO2. After 24 h we substituted the MEGACELL 
medium with DMEM (Euro Clone) supplemented with 
different trophic factors to induce neuronal differentiation. 
Brain Derived Growth Factor (Sigma-Aldrich) 50 ng/mL, 
Platelet Derived Growth Factor-AA 10 ng/mL (Sigma-
Aldrich), and 135 ng/mL basic Fibroblast Growth Factor 
(BD Biosciences) were administered singularly to the cells. 
Control cells were incubated in DMEM alone. Medium 
was replaced every 3 d for 14 d.
 After differentiation, cultures were fixed with 4 % 
paraformaldehyde in pH 7.4 PBS for 30 min at room 
temperature. After three washes, fixed cells were incubated 
with blocking solution containing 10 % FBS and 0.1 % 
TritonX-100 (Sigma-Aldrich) in PBS for 1 h at room 
temperature.
 Primary antibodies were added to 1 % FBS and 0.01 % 
TritonX-100 in PBS at 4 ºC overnight and included the 
followings: mouse monoclonal-anti-Map2; -anti-Map5, 
-anti beta III tubulin Tuj1; anti sulphatide O4; -anti glial 
fibrillary acid protein (GFAP) (Dako, Milan, Italy); rabbit 
monoclonal anti chondroitin sulphate proteoglycan Ng2 
(Dako). The secondary antibodies were FITC-conjugated 
Donkey anti-rabbit IgG 488 nm and rhodamine-conjugated 
goat anti-mouse IgG 594 nm (Molecular Probes, Eugene, 
OR, USA).
 Slides were fixed using Vectashield with DAPI (Vector 
Laboratories, DBA Italia, Segrate, Italy) to counter-stain 
nuclei. As internal control, untreated DSCs were fixed and 
labelled with the same antibodies as above described.
 All the fluorescence signals were analysed with a Nikon 
TE 2000S microscope at excitation/emission wavelengths 
of 540/565 nm (TRITC, red), 450/505 nm (FITC, green), 
and 340/400 nm (DAPI, blue). Images were acquired 
with the Olympus F View II camera and the Olympus 
Cell^F software (Olympus Italia, Segrate, Milan, Italy). 
Experiments were made in quadruplicate.
In vivo transplantation
After in vitro differentiation, we performed transplantation 
experiments in vivo, designed to observe if the obtained 
differentiation in vitro was, at least, maintained in vivo. To 
this aim, SSEA-4 sorted DFC pellets were re-suspended in 
0.3 mL culture medium and layered onto Gingistat (Gaba 
Vebas, San Giuliano Milanese, Italy) a commercial type 1 
collagen, made of native lyophilised collagen from animal 
origin (equine). Collagen sponges were cut in 10x10 mm 
squared pieces and then sterilised under UV exposure 
within Petri dishes, and incubated at 37 ºC with 5 % CO2 for 
30 min to allow colonisation. Plating efficiency assay was 
performed counting free-floating cells 30 min after plating.
 Cells were placed onto the same scaffolds and used 
as controls. Scaffolds colonised with DFC cells were 
transplanted in subcutaneous pockets on the back of 12 nude 
mice (NU/NU, Charles River). Animals were sacrificed 30 
or 60 d after transplantation. Procedures were approved 
by our internal small animal ethics committee. After 
each sacrifice the transplant area was dissected and used 
for normal histology as well as for immunofluorescence 
in order to demonstrate the human origin of the tissue 
(HLA antibody, Santa Cruz). Experiments were made in 
quadruplicates.
Statistical analysis
Student t-test (two-tailed) was used for statistical 
evaluation. Level of significance was set at p < 0.05.
Results
Dental follicle culture
We obtained 53 primary cell lines from sixty tissue 
specimens cultured in MEGACELL at 10 % FBS and 
frozen in 1 mL FBS/10 % DMSO under liquid nitrogen. 
These lines were capable of growing up to 23 culture 
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passages. All the other cell samples were considered “early 
passages” because the cells become senescent between the 
2nd and 4th culture passage. All cell lines showed cells 
with fibroblast shape. Any differences in terms of growth 
and morphology were detected to different passages of 
culture. All experiments were performed at 5th culture 
passage. At this passage, we did not observe variations 
on the pluripotent potential in term of gender and age of 
donors, also because we used only follicles from germs in 
which dental roots were completely absent.
Antigenic characterisation
Fluorescence activated cell assays, performed at day 15 
after cell selection, showed that follicle cells expressed high 
levels of positivity for SSEA-4, OCT-4, TRA1-60, TRA1-
81, and flk-1 antigens, which are all markers of embryonic 
stem cells. The percentage of positivity was about 80 % 
for each embryonic marker (Fig. 1A). In addition, cells 
were positive for CD90 and CD133 antigens, although at 
lower percentages. Then we challenged follicle cells for 
neural crest cell markers, including CD56, Brn3a, Tuj1, and 
SMA. In this case, the percentage of positivity was about 
30 % (Fig. 1A). Conversely, positivity for differentiated 
neuron antigens, including p75, was very low (Fig. 1A).
 Furthermore, with RT-PCR, we found that these cells 
expressed high levels of mRNA for embryonic stem cell 
transcription factors, including Nanog and Rex-1 (Fig. 1B).
Fig. 1. (A) Fluorescence activated analysis of dental follicle cells (DFCs) shows a strong positivity for SSEA-4, 
OCT-4, TRA 1-60, TRA 1-81, CD 90, CD133, CD56, flk-1, Brn3a, Tuj1, SMA and p75; (B) PCR analysis for 
Nanog and REX-1; (C) ALP histochemical assay. The whole population is clearly positive (blue staining). (scale 
bar = 250 µm); (D) The telomerase activity of DFCs (SSEA-4+sorted cells) shows that SSEA-4+ DFCs, sorted at 
day 0, display high levels of this activity compared to DFCs differentiated in adipogenic medium for 18 d (shown 
in both gel and histogram) and for 46 d (shown in the histogram).
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Fig. 2. (A) SSEA-4+ cells forming spheres in vitro (scale bar=50 μm); (B) Fluorescence activated cell sorter analysis 
on DFCs forming spheres showing an average positivity of 99% for SSEA-4, OCT-4, TRA 1-60 and TRA 1-81. (C) 
Blastocyst injection of GFP+/DFCs. Fluorescent plus contrast phase microscopy observation reveals the presence of 
fluorescent cells within the inner cell mass, 24 h after injection (scale bar = 50 µm); (D) 48 h after injection (scale 
bar = 50 µm); and (E) 72 h after injection (scale bar = 50 µm).
Fig. 3. Bone differentiation of DFCs: (A) Histochemical assay indicates that differentiated cells were positive for ALP 
(scale bar = 250 µm); (B) Representative image of Osteocalcin positivity (scale bar = 250 µm); (C) Representative 
image of Bone Alkaline Phosphatase (BAP) positivity (scale bar = 250 µm); (D) Representative image of Bone 
SialoProtein (BSP) positivity (scale bar = 250 µm); (E) Representative image of Type I Collagen positivity (scale 
bar = 250 µm); (F) Representative image of Runx-2 positivity (scale bar = 250 µm).
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 At this stage, cells were also markedly positive for 
ALP: actually, positivity within the flask was diffuse in 
the whole cell layer (Fig. 1C).
Telomerase activity
Having found all the previous shown embryonic features, 
we decided to perform assays in order to observe follicle 
cell telomerase activity, which is a commonly used 
parameter showing the lifespan of a cell and which is 
highly expressed in embryonic stem cells. We measured 
telomeres with the TRAPeze ELISA detection Kit, and 
we found a considerably high level in SSEA-4+ sorted 
follicle cells compared to the control (Fig. 1D). The assay 
was performed using the same cell population observed 
at a different time of differentiation (18 and 46 d) induced 
by adipogenic medium. As shown in this study, the rate of 
telomerase activity is considerably high in SSEA-4+ cells 
at day 0 and significantly decreases in SSEA-4+ cells after 
18 and 46 d of adipogenic differentiation. This observation 
is important because this high level of telomerase activity 
Fig. 4. Image showing adipogenic, myogenic and smooth muscle differentiation of DFCs: (A) Control of non-dif-
ferentiated cells for PPARγ (scale bar = 50 µm); (B) DFC-derived adipocytes immunostained for PPARγ in red 
(scale bar = 50 µm); (C) Control of non-differentiated cells for Adiponectin (scale bar = 250 µm); (D) DFC-derived 
adipocytes immunostained for Adiponectin in red (scale bar = 250 µm); (E) smooth muscle differentiation of DFCs. 
Image representative of SMA positivity (scale bar = 50 µm); (F) myogenic differentiation. DFCs were co-cultured 
with mouse C2C12 myotubes. Myosin-positive fibres are marked with a polyclonal anti-myosin (FITC), human nuclei 
are marked with a nuclear antilamin A and C (TRITC). Two human nuclei, in red, within a myotube demonstrate 
cell fusion (scale bar = 50 µm).
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Fig. 5. Image showing neural differentiation of DFCs. (A) TUJ1, MAP-2, MAP-5, neuronal differentiation by 
BDNF (scale bar = 50 µm); (B) NG2, O4, oligodendrocyte differentiation by PDGFAA (scale bar = 50 µm); (C) 
GFAP, astrocyte differentiation by FGF (scale bar = 50 µm).
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was found to be comparable to that usually detected 
in embryonic cells. The latter further demonstrates the 
similarity of these cells with embryonic cells.
Sphere cluster formation (embryoid bodies)
Then we organised other experiments in order to ascertain 
the ability of DFCs to grow in suspension in a serum free 
medium supplemented with growth factors. This method 
was described for the first time to select neural stem cell 
through neurosphere formation and has been largely used 
as a selection method for embryonic stem cells (Reynolds 
et al., 1992; Reynolds and Weiss, 1992). In fact, embryonic 
cells, selected on the basis of their ability to form sphere 
clusters, commonly called “Embryoid Bodies”, were found 
to be able to differentiate and build different tissues of the 
three embryonic germ layers when injected into permissive 
hosts or stimulated with different media in vitro. In our 
experiments, we found that DFCs were able to form sphere 
clusters; actually, embryoid bodies were observed already 
after 24 h in SSEA-4+ cultures (Fig. 2A), while SSEA-
4- cells, used as controls, did not form spheres. After 7 
d of culture, spheres obtained from SSEA-4+ cells were 
seeded in standard plates with 10 % FBS. Cells migrated 
to from the spheres within a few hours and adhered to the 
bottom of the flasks, assuming a polygonal shape. These 
cells resulted to be smaller in size when compared with 
SSEA-4- cells. After a week, we performed additional tests 
for SSEA-4, OCT 4, TRA 1-60, and TRA1-81 antigen on 
adhered cells. We found that almost all the cells obtained 
from spheres were SSEA-4+, OCT 4+, TRA 1-60+, and 
TRA1-81+ (Fig. 2B), whereas the cells that did not form 
spheres were completely negative for all antigens. This 
result further emphasises the “embryonic” nature and 
behaviour of DFCs.
Blastocyst injections
In order to further observe their embryonic features, 
we performed a series of key experiments designed to 
test whether DFCs directly contribute to embryonic 
development. To this end, we microinjected these cells 
into mouse blastocysts. In our first set of experiments, the 
cells were injected into murine blastocysts isolated from 
C57BL/6 donors on day 3.5 of gestation.
 In total, 30 blastocysts were microinjected with GFP+/
DFCs. Ten of these injected blastocysts were examined 
under fluorescence microscope (Nikon Instruments, 
Florence, Italia). Interestingly, in each blastocyst, GFP+/
DFCs cells were found within the inner cell mass. Injected 
cells were viable at 24 h (Fig. 2C), 48 (Fig. 2D) and 72 h 
after the injection when GFP+/DFCs cells were integrated 
with blastomeres (Fig. 2E). This evidenced that cells were 
able to induce the formation of chimeras. Only in one case 
we found that the blastocyst expelled the injected GFP+ 
cells after 24 h.
 In order to produce chimeric formation, 20 injected 
blastocysts were implanted in mouse uterus. After 12.5 d 
of pregnancy they were explanted and examined for human 
DNA. Human DNA was not detected in the samples.
Teratoma formation
In order to explore and evidence all the characteristics of 
these cells, we performed DFC transplantation experiments 
in nude mice, following the design described in the M&M 
section. Our aim was to observe the eventual capability of 
DFCs to give rise to teratomas after transplantation. In all 
of the 12 cases DFC injections did not lead to teratoma or 
tumour formation in mice. This seems to be the only main 
difference between DFCs and embryonic cells.
Differentiation in vitro
In addition to all the previous experiments, we performed 
classical differentiation assays with the aim to demonstrate 
the pluripotency of DFCs.
Osteoblast and bone differentiation
After 3 weeks of cell culture with basal medium and 
without passages, cells started to induce the formation of 
hemispheric ossification centres. The appearance of these 
Fig. 6. Image showing the results of SSE4-sorted DFC-transplanted cells in nude mice. After 60 d cells formed either 
a vascularised adipose tissue (A,B,C) or a skeletal muscle (D,E,F) both positive for HLA-1 (nuclei are stained with 
DAPI). Merge in C and F. (scale bars = 250 µm).
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centres of mineralisation was scattered within each flask, 
with several centres per flask. They then grew to build 
rounded 3D structures, which became macroscopically 
observable at day 40. Thereafter, the tissue continued 
to expand and, by day 50, several calcified nodules of 
newly synthesised tissue were evident in each flask. 
These differentiated cells were positive for ALP (Fig. 
3A) and osteocalcin at immunofluorescence (Fig. 3B). 
Using antibodies specific for bone matrix proteins, we 
found that all the newly produced tissue was positive 
to protein markers present in mineralised bone (Fig. 3 
C,D,E), including bone alkaline phosphatase (BAP), bone 
sialoprotein (BSP), and collagen type I. The transcription 
factor RUNX-2 was also markedly expressed (Fig. 3F).
Adipogenic differentiation
Adipocyte differentiation was stimulated with 
dexamethasone. Cells cultured in this adipogenic 
medium differentiated into adipocytes, as assessed by 
specific staining for lipids. After 4 weeks from selection, 
approximately 50 % of cells differentiated into adipocytes 
containing a lipid content strongly positive for PPAR-γ (Fig. 
4A,B) and adiponectin (Fig. 4C,D). The cytoarchitecture 
was typical of multivacuolar pre-adipocytes.
Skeletal muscle differentiation
In order to stimulate differentiation into skeletal muscular 
cells, sorted cells were co-cultured with C2C12, and 
tested for their capacity to fuse with them. Double 
immunofluorescence staining revealed 32 % of cell fusion 
(Fig. 4E).
Smooth muscle differentiation
To stimulate smooth muscle differentiation, cells were 
placed in MEGACELL medium with 2 % FBS and 10 ng/
mL TGFβ. Smooth muscle differentiation was obtained in 
4-5 d. Immunofluorescence performed using SMA antigen 
showed that the differentiation ratio was of 35-38 % (Fig. 
4F).
Astrocytes, olygodendrocytes and neuron differentiation
To assess the pluripotency of DFCs toward cells of neural 
lineages, we treated these cells with different tropic factors 
selectively.
 To generate neurons, oligodendrocytes and astrocytes 
were incubated with BDNF (50 ng/mL,), PDGF-AA (10 ng/
mL), and bFGF (135 ng/mL) respectively for 14 d. At this 
time point, we performed an indirect immunocytochemistry 
analysis to evaluate the expression of selective markers of 
neural differentiation.  After 14 d, cells treated with BDNF 
expressed neuronal markers: Tuj-1, MAP-2, and MAP-5 
(Fig. 5A). Interestingly, the expression of Tuj-1 indicates 
the presence of mature neurones. Yet, when DFCs were 
treated with PDGF-AA, the oligodendrocytic markers Ng2 
and O4 were expressed at high levels (Fig. 5B). Similarly, 
cells treated with FGF expressed the astrocytic marker 
GFAP (Fig. 5C).
 Accordingly with the expression of neural markers, 
the morphology of treated cells was changed and appeared 
neural-like. As expected, expression of neural proteins and 
changes in cell morphology were not observed in untreated 
DFCs.
 In summary, DFCs have neuronal differentiation 
capabilities in vitro with the following percentages: 
neurons 19 %, oligodendrocytes 18 %, and astrocytes 17 %.
In vivo transplants
SSEA-4 DFCs were transplanted using a collagenous 
scaffold, into nude mice. Results showed that, after in vivo 
transplantation, different human tissues were obtained:  an 
adipose tissue of Human origin (Fig. 6A,B,C) a Human 
adult bone and a Human skeletal muscle (Fig. 6D,E,F), 
while the scaffold was completely reabsorbed. In all the 
cases a blood supply was present and a vascular network 
established.
Discussion
Stem cells participate in organogenesis, cell turnover, and 
repair from injury. These processes require cell trafficking, 
the oriented or directed movement of cells toward a 
particular anatomic destination (Laird et al., 2008). In the 
human adult body, other than bone marrow, one of the main 
sources of mesenchymal stem cells are niches that store 
these cells that are recruited upon request (Gurtner et al., 
2008; Paino et al., 2010; Rim et al., 2005; Shi et al., 2010; 
Sviderskaya et al., 2009).
 Adult stem cells, as well as progenitor cells, are 
present within the body inside these niches and are 
unipotent, self-committed cells. Only in some cases, these 
cells can efficiently generate more cytotypes or a whole 
tissue. Dental pulp stem cells, which are derived from 
ectomesenchymal cells with the participation of neural 
crest-cell migration during organogenesis, can differentiate 
into osteoblasts, adipose cells, neurons, and smooth muscle 
and fuse their nuclei with murine myotubes (d’Aquino et 
al., 2007; Laino et al., 2005; Laino et al., 2006). Moreover, 
stem cells (SCs) with neural crest characteristics have been 
isolated from the bulge area of cultured human hair follicles 
(HFs) exhibiting clonal multipotency that can give rise to 
myogenic, melanocytic, and neuronal cell lineages (Yu et 
al., 2006; Yu et al., 2010).
 Embryologically, teeth are ectodermal organs 
originating from sequential reciprocal interactions between 
oral epithelial cells (ectoderm) and cranial neural crest-
derived mesenchymal cells. The epithelial cells give rise 
to enamel forming ameloblasts, and the mesenchymal cells 
form all other differentiated cells, e.g., dentine forming 
odontoblasts, pulp, periodontal ligament (Volponi et al., 
2010).
 Odontogenic tissues, deriving from the neural crest, 
remain undifferentiated during the first years of postnatal 
life, after which they develop the dental and periodontal 
structures of the secondary dentition. During tooth 
formation, the dental bud and crown are surrounded by 
an envelope that can be compared to a “placenta”: this is 
called the “dental follicle” and provides undifferentiated 
cells for dental tissue building. The dental follicle persists 
in the adult because of its role in dental organogenesis, 
which occurs in humans up to the 12th year of life.
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 Therefore, we undertook this study with the aim to 
characterise the cells of the early stage dental follicle 
when it has not yet started to produce dental roots and 
cementum in particular. We found that the expression of 
typical ES (Embryonic Stem cell) markers, including the 
transcription factors Oct-4, Nanog, and REX-1, on cells 
of the dental follicle is of such a high level as to be of 
extreme interest. Actually, these cells, called DFCs, not 
only express Oct-4, Rex-1, and Nanog, but also SSEA-
4, TRA1-60, TRA1-81, CD133, and CD90 at very high 
percentages (from 80 % up to 100 %): all those antigens 
are markers usually expressed by embryonic pluripotent 
stem cells. Since SSEA-4, Oct-4, and Nanog are specific 
markers of embryonic stem cells (Pan and Thomson, 2007; 
Stojkovic et al., 2004), epiblastic cells, and primordial 
germ cells (Virant-Klun et al., 2008) the presence of  DFCs 
in an adult tissue reinforces the concept that they are a 
population of pluripotent or embryonic-like stem cells 
that directly belong to the neural crest. Actually, the 100 % 
of positivity for the CD56 antigen reinforces the thought 
that these cells directly derive from neuroectoderm. In 
addition, ES properties include not only the expression of 
Oct-4, Nanog, and Rex-1, as well as pluripotency, but also 
the capability for sphere formation under the appropriate 
conditions (Reynolds et al., 1992; Reynolds and Weiss, 
1992), blastocyst inner cells mass integration (Durr et al., 
2003; Harder et al., 2002), and high telomerase expression. 
These are all properties of DFCs, as demonstrated in this 
study. In addition, we did not observe variations on the 
pluripotent potential in term of gender and age of donors, 
because we used only follicles from germs in which dental 
roots were completely absent and at 5th passage of culture. 
Regarding to chimeras formation, we tried to find human 
cells in mouse embryo of 12.5 days by sectioning and 
screening for the presence of any green fluorescent cells, 
or by total DNA extraction screening for the presence of 
human related DNA sequences. Unfortunately, we were not 
able to detect human DNA. Mouse embryonic development 
is much different from that human, and probably the 
different pathways involved did not allow human cells 
to proliferate and contribute to organ formation. Besides 
this, there is the chance that a low number of human cells 
integrate in mouse tissue but were not detected by the 
assays we performed. Although this, the integration with 
blastomeres, followed up to 72 h is a rare and uncommon 
event. Therefore, we stress the importance of the presented 
data, obtained in almost all the cases, and in a considerable 
number of injected blastocycts, evidencing the tendency of 
these cells to form chimeras, other than their “embryonic” 
features and behaviour. DFCs did not form teratomas, after 
injection into nude mice (12 injected nude mice). Albeit 
teratoma formation is a general attitude of embryonic stem 
cells (Nussbaum et al., 2007; Pomper et al., 2009),  this 
result means that cells share many features with embryonic 
cells, but not all of them, demonstrating that these cells 
do not have a cancerous potential and, therefore, can be 
ready for use in therapeutic applications without creating 
oncological problems.
 It is known that culture environments alter the 
patterning of cells in ways that modify their fates and 
even their developmental potential (Joseph and Morrison, 
2005). Similar concerns have been addressed in neural 
crest stem cells, leading to the conclusion that after culture 
these cells often lose or change their properties, so that in 
many cases it is much better to select them directly by flow 
cytometry (Bixby et al., 2002; Morrison and Spradling, 
2008; Morrison et al., 1999). Therefore, we have used 
fluorescence activated cytometry and found high levels of 
all embryonic markers, demonstrating that in this procedure 
does not reduce the capabilities of dental follicle cells.
 Regarding dental structures, our group has obtained 
significant results demonstrating that dental pulp stem cells 
differentiate into several lineages including skeletal muscle 
(Spath et al., 2010) and mainly into osteoblasts that give 
rise to bone (Laino et al., 2005; Laino et al., 2006), which 
after transplantation is remodelled into adult lamellar bone 
containing vessels (d’Aquino et al., 2007). These cells 
have been successfully used for human grafts (d’Aquino 
et al., 2009); moreover, these cells have been used to test 
their performance on different scaffolds, demonstrating an 
involvement of cadherin and integrins in their behaviour 
(Graziano et al., 2007; Mangano et al., 2010). Similar 
tissue-forming capabilities are shown by DFCs.
 To date, the dental follicle has been found to be mainly 
involved in cementogenesis (Handa et al., 2002). To our 
knowledge, there are no studies evidencing that dental 
follicular cells not only express embryonic markers but 
also have many other features and behaviours of embryonic 
cells as we have reported here. Some studies have shown 
that the dental follicle contains committed precursor cells 
that give rise to cementoblasts, periodontal ligament, and 
osteoblasts (Morsczeck et al., 2005; Yokoi et al., 2007). 
It has been also encountered as a stem cell niche together 
with dental pulp and periodontal ligament (Mitsiadis et al., 
2007).
 Because of its composition, biology, and features 
the dental follicle may be considered to be composed 
of cells originating from neuroectodermal structures 
during development that retain their characteristics and 
capabilities in the adult. After birth, these cells play 
a crucial role in steady state conditions during tissue 
turnover. Furthermore, on tissue damage, these cells 
could be recruited from their niche and home to damaged 
areas in order to participate in several cell and tissue 
repair processes. Our data, summarised in Table 1, have 
evidenced that these pluripotent cells can be paramount 
for several therapeutic uses. Actually, DFCs are cells 
with many features of embryonic stem cells: in particular, 
their antigen expression and high levels of mRNAs of 
embryonic transcription factors, and a telomerase activity 
that is comparable with that of embryonic cells points to an 
embryonic cell status. Adding to this their ability to form 
embryoid bodies, their capability integrate in the inner cell 
mass after being injected in a murine blastocyst, and their 
efficient differentiation into several cytotypes including 
osteoblasts, neurons, glial cells, vessels, adipose cells, and 
many other cell types, highlights the potential interest of 
these cells.
 In vivo transplantation experiments clearly demonstrate 
that DFCs pluridifferentiation is maintained after grafting 
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and that either adipose or skeletal muscle tissues were 
obtained. Moreover, a vascular supply, which is of 
paramount importance, was observable in all the cases.
 In conclusion, in this study we have shown that DFCs 
have several capabilities and features including expression 
of embryonic markers in a high percentage of cells 
(ranging from 80 % up to 100 %); expression of markers 
of embryonic neural crest cells; high levels of telomerases 
and a related long lifespan similar to embryonic stem cells; 
formation of embryoid bodies in culture; integration within 
the inner cell mass of murine blastocysts after injection; 
differentiation toward all lineages (pluripotency), which 
is maintained after in vivo grafting; and complete and 
vascularised bone, skeletal muscle and adipose tissue 
generation. Taken together, our findings open up a new 
scenario in which these cells, which are present in an adult 
human body, can be used for clinical application, although 
their particular antigenic profile, being in the adult body. 
We think that they will help the understanding of tissue 
regeneration and in solving several clinical problems.
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